PharmaBoardroom

France provides a unique environment for dermo-cosmetics companies such as Pierre Fabre, Uriage, and Galderma to thrive in terms of the industry's…

The following chart shows the number of clinical trials in Italy per year. Peaking in 2008 and slumping slightly shortly after, the numbers have…

Pfizer Switzerland’s Pamela Alexa discusses launching Xeljanz (tofacitinib), a treatment for adult patients with moderate to severe active…

Known as “Ireland’s university of Enterprise,” Dublin City University’s research and educational philosophy is very much informed by the…

Patricia Ostrosky, general director of the Institute of Biomedical Research in Mexico, details current research subjects and calls for greater…

Reckitt Benckiser’s General Manager for the CEE region, Lajos Magyari, discusses the strength of the company’s current portfolio, the importance…

Professor Dr. Robert Riener speaks about the much anticipated Cybathlon event and its importance to technology transfer, the Swiss education…

The president of the Czech Academy of Sciences highlights the responsibility of leading scientists to consider the real life application of their…

As President of Biopharma Activities for Merck in France, Pierre-Henry Longeray reveals how France is the third ranked affiliate after the US and…

Dr. Teresa Corona Vázquez, the general director of one of the leading neuroscience institutions in Latin America, details their most important…

The Country Head Commercial Business of Cipla Czech Republic reviews the challenges faced since Cipla began Czech operations two years ago, the…

While the Italian clinical research community works to an excellent standard of quality, and is relatively competitive in terms of costs, regulatory…